Abstract: The present invention discloses processes for producing native, depigmented and polymerised allergen extracts. The invention further discloses extracts produced via the processes, and pharmaceutical and vaccine compositions comprising the extracts, for diagnosis and treatment of allergy.
Abstract: The present invention discloses processes for producing native, depigmented and polymerised allergen extracts. The invention further discloses extracts produced via the processes, and pharmaceutical and vaccine compositions comprising the extracts, for diagnosis and treatment of allergy.
Abstract: The present invention discloses processes for producing native, depigmented and polymerised allergen extracts. The invention further discloses extracts produced via the processes, and pharmaceutical and vaccine compositions comprising the extracts, for diagnosis and treatment of allergy.
Abstract: The present invention discloses processes for producing native, depigmented and polymerized allergen extracts. The invention further discloses extracts produced via the processes, and pharmaceutical and vaccine compositions comprising the extracts, for diagnosis and treatment of allergy.
Abstract: The present invention discloses processes for producing native, depigmented and polymerised allergen extracts. The invention further discloses extracts produced via the processes, and pharmaceutical and vaccine compositions comprising the extracts, for diagnosis and treatment of allergy.
Abstract: It comprises a combination of glycerin, niacinamide, and an extract of Fucus Serratus, to topical pharmaceutical or cosmetic compositions containing them, processes for their preparations, as well as their pharmaceutical use in the prophylaxis and/or treatment of disease or conditions that transcur through a deficit of maturation of the cornified envelope, and their cosmetical use as a skin care agent, skin barrier recovery agent, and moisturizer.
Type:
Application
Filed:
May 26, 2011
Publication date:
March 21, 2013
Applicant:
LABORATORIOS LETI, S.L.
Inventors:
Noemí Serra-Baldrich, Silvia García Bertran
Abstract: The invention relates to composition comprising an L3 and/or an L5 source and optionally an adjuvant for the preparation of a medicine for the treatment or prevention of a parasitic disease and to its diagnostic use of said parasitic disease.
Type:
Application
Filed:
May 11, 2012
Publication date:
October 18, 2012
Applicant:
Laboratorios LETI S.L.
Inventors:
Carlos Alonso-Bedate, Manuel Soto-Alvarez, Laura Ramirez Garcia